Anti-HBV strategy for cancer patients with HBV infection in perichemotherapy period

doi:10.3969/j.issn.1672-3384.2017.06.002

PDF(560 KB)

Clinical Medication Journal ›› 2017, Vol. 15 ›› Issue (6) : 5-8. DOI: 10.3969/j.issn.1672-3384.2017.06.002

Review

Anti-HBV strategy for cancer patients with HBV infection in perichemotherapy period

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 15(6): 5-8 https://doi.org/10.3969/j.issn.1672-3384.2017.06.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(560 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2017-04-11	2017-06-24
Issue Date
2017-06-24

Please choose a citation manager

Content to export